Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-301996

Chief Legal Officer sold 30,000 shares at an average $17.96 ($538,868)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mazzariello Gina Chief Legal Officer 2026-07-09 Sale 10b5-1 −15,000 $18.32 $274,746 194,090 D: show line 1 in the form
Mazzariello Gina Chief Legal Officer 2026-07-10 Sale 10b5-1 −15,000 $17.61 $264,122 179,090 D: show line 2 in the form
Open-market sales · 30,000 sh · avg $17.96 · $538,868
Loading xslF345X06/ownership.xml…